vs
欧加隆（OGN）与Primo Brands Corp（PRMB）财务数据对比。点击上方公司名可切换其他公司
Primo Brands Corp的季度营收约是欧加隆的1.1倍（$1.6B vs $1.5B），欧加隆净利率更高（10.0% vs 1.7%，领先8.3%），Primo Brands Corp同比增速更快（0.8% vs -3.5%），过去两年Primo Brands Corp的营收复合增速更高（19.7% vs -4.7%）
欧加隆是一家总部位于美国新泽西州泽西城的制药企业，核心业务覆盖生殖医学、避孕、精神科、激素替代疗法及麻醉领域的药物研发与生产。公司所有产品均在美国境外生产，同时美国市场贡献了其三分之一的营收。
Primo Brands Corp是一家美加合资饮用水企业，主营多规格桶装水、饮水机、自助补水设备及净水家电，总部位于美国佛罗里达州坦帕市，服务覆盖美国、加拿大、欧洲及以色列的住宅与商业客户。
OGN vs PRMB — 直观对比
营收规模更大
PRMB
是对方的1.1倍
$1.5B
营收增速更快
PRMB
高出4.3%
-3.5%
净利率更高
OGN
高出8.3%
1.7%
两年增速更快
PRMB
近两年复合增速
-4.7%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.6B |
| 净利润 | $146.0M | $27.3M |
| 毛利率 | 53.6% | 28.6% |
| 营业利润率 | — | 8.5% |
| 净利率 | 10.0% | 1.7% |
| 营收同比 | -3.5% | 0.8% |
| 净利润同比 | 67.8% | -4.9% |
| 每股收益（稀释后） | $0.55 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OGNPRMB
| Q1 26 | $1.5B | $1.6B | ||
| Q4 25 | $1.5B | $1.6B | ||
| Q3 25 | $1.6B | $1.8B | ||
| Q2 25 | $1.6B | $1.7B | ||
| Q1 25 | $1.5B | $1.6B | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.6B | $0 | ||
| Q2 24 | $1.6B | $1.3B |
净利润OGNPRMB
| Q1 26 | $146.0M | $27.3M | ||
| Q4 25 | $-205.0M | $-13.0M | ||
| Q3 25 | $160.0M | $16.8M | ||
| Q2 25 | $145.0M | $27.6M | ||
| Q1 25 | $87.0M | $28.7M | ||
| Q4 24 | $109.0M | — | ||
| Q3 24 | $359.0M | $-2.0K | ||
| Q2 24 | $195.0M | $54.5M |
毛利率OGNPRMB
| Q1 26 | 53.6% | 28.6% | ||
| Q4 25 | 49.2% | 27.7% | ||
| Q3 25 | 53.5% | 29.9% | ||
| Q2 25 | 54.8% | 31.3% | ||
| Q1 25 | 55.6% | 32.3% | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.4% | 32.7% |
营业利润率OGNPRMB
| Q1 26 | — | 8.5% | ||
| Q4 25 | -9.8% | 1.2% | ||
| Q3 25 | 15.2% | 8.3% | ||
| Q2 25 | 14.4% | 6.5% | ||
| Q1 25 | 6.7% | 9.5% | ||
| Q4 24 | 8.1% | — | ||
| Q3 24 | 13.1% | — | ||
| Q2 24 | 14.6% | 12.1% |
净利率OGNPRMB
| Q1 26 | 10.0% | 1.7% | ||
| Q4 25 | -13.6% | -0.8% | ||
| Q3 25 | 10.0% | 1.0% | ||
| Q2 25 | 9.1% | 1.6% | ||
| Q1 25 | 5.8% | 1.8% | ||
| Q4 24 | 6.8% | — | ||
| Q3 24 | 22.7% | — | ||
| Q2 24 | 12.1% | 4.1% |
每股收益（稀释后）OGNPRMB
| Q1 26 | $0.55 | $0.07 | ||
| Q4 25 | $-0.78 | $-0.03 | ||
| Q3 25 | $0.61 | $0.04 | ||
| Q2 25 | $0.56 | $0.07 | ||
| Q1 25 | $0.33 | $0.08 | ||
| Q4 24 | $0.42 | — | ||
| Q3 24 | $1.38 | $-20.00 | ||
| Q2 24 | $0.75 | $0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | $5.2B |
| 股东权益账面价值 | — | $3.0B |
| 总资产 | — | $10.6B |
| 负债/权益比越低杠杆越低 | — | 1.74× |
8季度趋势，按日历期对齐
现金及短期投资OGNPRMB
| Q1 26 | — | — | ||
| Q4 25 | $574.0M | $376.7M | ||
| Q3 25 | $672.0M | — | ||
| Q2 25 | $599.0M | — | ||
| Q1 25 | $547.0M | — | ||
| Q4 24 | $675.0M | — | ||
| Q3 24 | $763.0M | — | ||
| Q2 24 | $704.0M | — |
总债务OGNPRMB
| Q1 26 | — | $5.2B | ||
| Q4 25 | $8.6B | $5.2B | ||
| Q3 25 | $8.8B | $5.1B | ||
| Q2 25 | $8.9B | $5.1B | ||
| Q1 25 | $9.0B | $5.0B | ||
| Q4 24 | $8.9B | — | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — |
股东权益OGNPRMB
| Q1 26 | — | $3.0B | ||
| Q4 25 | $752.0M | $3.0B | ||
| Q3 25 | $906.0M | $3.2B | ||
| Q2 25 | $733.0M | $3.2B | ||
| Q1 25 | $542.0M | $3.3B | ||
| Q4 24 | $472.0M | — | ||
| Q3 24 | $493.0M | $-2.0K | ||
| Q2 24 | $144.0M | $-296.8M |
总资产OGNPRMB
| Q1 26 | — | $10.6B | ||
| Q4 25 | $12.9B | $10.6B | ||
| Q3 25 | $13.6B | $11.0B | ||
| Q2 25 | $13.5B | $11.0B | ||
| Q1 25 | $13.2B | $11.0B | ||
| Q4 24 | $13.1B | — | ||
| Q3 24 | $12.8B | $0 | ||
| Q2 24 | $12.2B | — |
负债/权益比OGNPRMB
| Q1 26 | — | 1.74× | ||
| Q4 25 | 11.49× | 1.72× | ||
| Q3 25 | 9.74× | 1.61× | ||
| Q2 25 | 12.14× | 1.57× | ||
| Q1 25 | 16.52× | 1.51× | ||
| Q4 24 | 18.81× | — | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $103.8M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 2.9% |
| 现金转化率经营现金流/净利润 | — | 3.80× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流OGNPRMB
| Q1 26 | — | $103.8M | ||
| Q4 25 | $141.0M | $203.1M | ||
| Q3 25 | $264.0M | $283.4M | ||
| Q2 25 | $220.0M | $155.0M | ||
| Q1 25 | $75.0M | $38.8M | ||
| Q4 24 | $390.0M | — | ||
| Q3 24 | $141.0M | $0 | ||
| Q2 24 | $332.0M | $102.5M |
自由现金流OGNPRMB
| Q1 26 | — | — | ||
| Q4 25 | $96.0M | $57.3M | ||
| Q3 25 | $218.0M | $167.7M | ||
| Q2 25 | $181.0M | $101.1M | ||
| Q1 25 | $43.0M | $-23.2M | ||
| Q4 24 | $335.0M | — | ||
| Q3 24 | $99.0M | — | ||
| Q2 24 | $300.0M | $61.4M |
自由现金流率OGNPRMB
| Q1 26 | — | — | ||
| Q4 25 | 6.4% | 3.7% | ||
| Q3 25 | 13.6% | 9.5% | ||
| Q2 25 | 11.4% | 5.8% | ||
| Q1 25 | 2.8% | -1.4% | ||
| Q4 24 | 21.0% | — | ||
| Q3 24 | 6.3% | — | ||
| Q2 24 | 18.7% | 4.7% |
资本支出强度OGNPRMB
| Q1 26 | — | 2.9% | ||
| Q4 25 | 3.0% | 9.4% | ||
| Q3 25 | 2.9% | 6.6% | ||
| Q2 25 | 2.4% | 3.1% | ||
| Q1 25 | 2.1% | 3.8% | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 2.0% | 3.1% |
现金转化率OGNPRMB
| Q1 26 | — | 3.80× | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.65× | 16.87× | ||
| Q2 25 | 1.52× | 5.62× | ||
| Q1 25 | 0.86× | 1.35× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 1.70× | 1.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OGN
| Established Brands | $880.0M | 60% |
| Women’s Health | $389.0M | 27% |
| Biosimilars | $173.0M | 12% |
PRMB
| Regional spring water | $801.2M | 49% |
| Purified water | $511.2M | 31% |
| Other | $208.2M | 13% |
| Premium water | $105.5M | 6% |
